Evaluation of tumor volume reduction of nasal carcinomas versus sarcomas in dogs treated with definitive fractionated megavoltage radiation: 15 cases (2010–2016)

Table 1 Patient Information collected from retrospective review

Patient	Breed	Age (years)/sex	Pre RT stage	Post RT stage	Pre RT histopathology	Post RT histopathology	Volume pre (cm³)	Volume post (cm³)	Volume change %	Total nasal volume (cm³)	MST (days)
1	Springer Spaniel	15 FS	I	I	Carcinoma	Carcinoma	27.2	5.3	− 80.10	66.9	487
2	Collie	13 FS	I	I	Carcinoma	Chondrosarcoma	11.1	4.9	− 55.80	83.4	467
3	Labrador Retriever	10 FS	I	I	Carcinoma	Carcinoma	36.5	6.3	− 82.70	118.6	406
4	Border Collie	13 MN	I	I	Chronic rhinitis	Adenocarcinoma	31.9	9.9	− 69.00	93.3	1141
5	Jack Russell Terrier	9 MN	III	III	Carcinoma	Carcinoma	21.9	4.2	− 80.80	48.4	266
6	Beagle	14 MN	II	II	Carcinoma	Carcinoma	17.4	6.8	− 60.90	57.7	435
7	Poodle	10 MN	II	III	Carcinoma	Carcinoma	11.1	6.7	− 39.60	14.7	324
8	Wheaton	12 MN	III	II	Myxosarcoma	Fibromyxosarcoma	30.9	5.7	− 81.60	92.5	435
9	Mixed breed	8 MN	II	II	Carcinoma	Carcinoma	13.5	3	− 77.80	62.3	Alive
10	Papillon	6 MN	II	I	Periglandular fibrosis	Chondrosarcoma	10.9	9	− 17.40	26.2	Alive
11	Mixed breed	9 FS	II	II	Osteosarcoma	Osteosarcoma	50.9	36.2	− 28.90	125.2	286
12	Jack Russell Terrier	14 FS	II	II	Chondrosarcoma	Chondrosarcoma	15.4	15.5	0.60	30.0	240
13	Beagle	11 MN	II	II	Carcinoma	Adenocarcinoma	10.4	5.7	− 45.20	42.2	Alive
14	Pitbull	6 FS	I	I	Sarcoma	Sarcoma	60	56.5	− 5.80	113.1	Alive
15	Boxer	5 FS	II	III	Chondrosarcoma	Chondrosarcoma	19.2	26.3	40.00	50.4	Alive

Staging using Modified Adams staging system (I–IV), MN, male neutered; FS, female spayed; MST, median survival time, RT, radiotherapy

ISSN: 1756-0500